• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
...

The Impact of COVID-19 is included in Metabolomics Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global metabolomics market looks promising with opportunities in various appliations, such as biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and personalized medicine. The global metabolomics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing research and development activities in pharmaceutical and biotechnology and increasing prevalence of chronic diseases.
 
Emerging trends, which have a direct impact on the dynamics of the industry, include  growing adoption of HPLC and UPLC technique for its most versatile separation method.  
 
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global metabolomics market report, please download the report brochure.
 
metabolomics
 
In this market, metabolomics instruments is the largest product and service of metabolomics, whereas biomarker discovery is the largest application. Growth in various segments of the metabolomics market are given below:

 
metabolomics
 
The study includes trends and forecast for the global metabolomics market by product and service, application, indication, and region as follows:
 
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Metabolomics Instruments
  • Separation Tools
  • Detection Tools 
  • Metabolomics Bioinformatics Tools and Services
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics
  • Personalized Medicine
  • Other Applications
By Indication [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Other Indications
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
  • United States
  • Canada 
  • Mexico
  • Europe
  • United Kingdom
  • German
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • The Rest of the World 
  • Brazil
Some of the metabolomics companies profiled in this report include Agilent Technologies, Bio- Rad Laboratories, Bruker Corporation, Danaher, Thermo Fisher Scientific, Waters Corporation, Shimadzu Corporation, LECO Corporation, Biocrates Life Sciences, and Metabolon.
 
Lucintel forecasts that metabolomics instruments will remain the largest product and service segment over the forecast period, as they are mostly used in research activities.
 
Within this market, biomarker discovery will remain the largest application segment over the forecast period due to rising prevalance of chronic diseases, such as cancer and diabetes, and increasing acceptance of cancer diagnostic tests.
 
North America will remain the largest region over the forecast period due to high per capita healthcare expenditure and increasing adoption of healthcare technology. 
 
 
Features of the Global Metabolomics Market
 
  • Market Size Estimates: Global metabolomics market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global metabolomics market size by various segments, such as product and service, application, and indication in terms of value.
  • Regional Analysis: Global metabolomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product and service, application, indication, and region for the global metabolomics market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global metabolomics market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
 
 
 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global metabolomics market by product and service (metabolomics instruments, separation tools and detection tools ) and metabolomics bioinformatics tools and services), application (biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications), indication (cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other indications), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global metabolomics market?
Q.5 What are the business risks and threats to the global metabolomics market?
Q.6 What are the emerging trends in this metabolomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this metabolomics market?
Q.8 What are the new developments in this metabolomics market? Which companies are leading these developments?
Q.9 Who are the major players in this metabolomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this metabolomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global metabolomics market?

 
 
Report Scope

Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)
2014-2019
Forecast Period